Enyedi A, Sarkadi B, Földes-Papp Z, Monostory S, Gárdos G
J Biol Chem. 1986 Jul 15;261(20):9558-63.
Membrane vesicles from human platelets were prepared by various disruption and isolation techniques reported in the literature to yield fractions of predominantly surface or intracellular membrane origin. ATP + Mg2+-dependent Ca2+ accumulation and the formation of acylphosphate intermediates of the calcium pump(s) were followed in parallel experiments, and the consequences of a limited proteolysis of the membranes examined. In all types of preparations active Ca2+ uptake had both oxalate-sensitive and insensitive fractions and calmodulin had no effect on the rate of Ca2+ uptake. Limited proteolysis by trypsin eliminated oxalate-sensitive Ca2+ uptake while it had no effect on the oxalate-insensitive fraction. The Ca2+-induced EP complex had an apparent molecular mass of 100-110 kDa in all of the preparations, the EP showing a broad or even duplicated line in most autoradiographies. Mild trypsin digestion resulted in the formation of 80-, 55-, and 35-kDa phosphorylated fragments. The 80-kDa fragment corresponded to the limit polypeptide found in the proteolyzed erythrocyte membrane Ca2+ pump, its phosphorylation was stimulated by lanthanum, and it appeared in a different time course than the smaller fragments. The molecular mass and the formation pattern of the latter species corresponded to the tryptic fragments in the sarcoplasmic reticulum Ca2+ pump. Based on these results we suggest that platelet membrane preparations contain two types of Ca2+ pump proteins, one similar to the sarcoplasmic reticulum-type and the other to the erythrocyte-type enzyme.
采用文献报道的各种破碎和分离技术制备人血小板膜囊泡,以获得主要源自表面或细胞内膜的组分。在平行实验中追踪ATP + Mg2 +依赖的Ca2 +积累以及钙泵酰基磷酸中间体的形成,并检测膜有限蛋白水解的后果。在所有类型的制剂中,活性Ca2 +摄取既有草酸盐敏感部分又有不敏感部分,钙调蛋白对Ca2 +摄取速率没有影响。胰蛋白酶的有限蛋白水解消除了草酸盐敏感的Ca2 +摄取,而对草酸盐不敏感部分没有影响。在所有制剂中,Ca2 +诱导的EP复合物的表观分子量为100 - 110 kDa,在大多数放射自显影片中EP显示出宽的或甚至重复的条带。温和的胰蛋白酶消化导致形成80 kDa、55 kDa和35 kDa的磷酸化片段。80 kDa片段对应于蛋白水解的红细胞膜Ca2 +泵中发现的极限多肽,其磷酸化受到镧的刺激,并且其出现的时间进程与较小片段不同。后一种物质的分子量和形成模式与肌浆网Ca2 +泵中的胰蛋白酶片段相对应。基于这些结果,我们认为血小板膜制剂含有两种类型的Ca2 +泵蛋白,一种类似于肌浆网类型,另一种类似于红细胞类型的酶。